Cargando…

Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study

OBJECTIVE: To develop and evaluate a multiprofessional modular medication management to assure adherence to capecitabine. METHODS: The study was conducted as a prospective, multicentred observational cohort study. All participants received pharmaceutical care consisting of oral and written informati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krolop, Linda, Ko, Yon-Dschun, Schwindt, Peter Florian, Schumacher, Claudia, Fimmers, Rolf, Jaehde, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717446/ https://www.ncbi.nlm.nih.gov/pubmed/23872296 http://dx.doi.org/10.1136/bmjopen-2013-003139

Ejemplares similares

Evaluation of patient-reported severity of hand–foot syndrome under capecitabine using a Markov modeling approach
por: Schmulenson, Eduard, et al.
Publicado: (2020)

Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care
por: Simons, Sven, et al.
Publicado: (2010)

Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity
por: Ortland, Imke, et al.
Publicado: (2022)

Developing tumor-specific PRO-CTCAE item sets: analysis of a cross-sectional survey in three German outpatient cancer centers
por: Günther, Maximilian, et al.
Publicado: (2023)

Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with Capecitabine
por: Cohen, Philip R
Publicado: (2017)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
por: Ren, Lanqi, et al.
Publicado: (2023)

Capecitabine-Associated Loss of Fingerprints: A Case Report of a 62-Year-Old Man With Colorectal Cancer Suffering From Capecitabine-Induced Adermatoglyphia
por: Dawood, Tasneem, et al.
Publicado: (2021)

Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer
por: Yip, Pui Lam, et al.
Publicado: (2023)

Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?
por: Saif, Muhammad W, et al.
Publicado: (2016)

Case Report: Various Abnormalities in Lipid and Glucose Metabolism Induced by Capecitabine
por: Anno, Takatoshi, et al.
Publicado: (2021)

Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis
por: Xun, Xueqiong, et al.
Publicado: (2022)

First Case of Foot Drop Associated with Capecitabine in a Patient with Thymidylate Synthase Polymorphism
por: Wilks, Andrew B, et al.
Publicado: (2017)

Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: She, Longjiang, et al.
Publicado: (2022)

Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice
por: Timmers, Lonneke, et al.
Publicado: (2016)

Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review
por: Ishida, Atsushi, et al.
Publicado: (2022)

Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis
por: Bai, Jie, et al.
Publicado: (2023)

The Impact of Prolonged Mechanical Ventilation on Overall Survival in Patients With Surgically Treated Brain Metastases
por: Schuss, Patrick, et al.
Publicado: (2021)

Outcome of Elderly Patients With Surgically Treated Brain Metastases
por: Heimann, Muriel, et al.
Publicado: (2021)

Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report
por: Liu, Wenzhi, et al.
Publicado: (2019)

The Evaluation of Dihydropyrimidine Dehydrogenase Enzyme Level in the Serum of Colorectal Cancer Iraqi Males on Fluoropyrimidine-Based Chemotherapy (Capecitabine)
por: Challoob, Muhtada A, et al.
Publicado: (2023)

Preoperative Metastatic Brain Tumor-Associated Intracerebral Hemorrhage Is Associated With Dismal Prognosis
por: Hamed, Motaz, et al.
Publicado: (2021)

Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study
por: Miki, Yoshitaka, et al.
Publicado: (2014)

Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study
por: Zhao, Jie, et al.
Publicado: (2022)

The use of capecitabine in daily practice: a study on adherence and patients’ experiences
por: Timmers, Lonneke, et al.
Publicado: (2012)

Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer
por: Polk, Anne, et al.
Publicado: (2016)

Clinical Complete Remission of An Advanced Gastric Adenocarcinoma After Camrelizumab Plus Chemotherapy Followed by Camrelizumab Plus Capecitabine: A Case Report
por: Lin, Jieheng, et al.
Publicado: (2021)

Durable effect of pyrotinib plus capecitabine in HER-2+ breast cancer patient undergoing peritoneal dialysis: A case report and literature review
por: Jin, Xiangting, et al.
Publicado: (2022)

Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer
por: Kawakami, Kazuyoshi, et al.
Publicado: (2017)

UN takes aim at small arms.
por: Greene, L A
Publicado: (2001)

Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial
por: Zhu, Jun, et al.
Publicado: (2021)

Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study
por: Chen, Yongbiao, et al.
Publicado: (2023)

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
por: Guan, Xiuwen, et al.
Publicado: (2020)

Ganglioside Monosialic Acid Alleviates Peripheral Neuropathy Induced by Utidelone Plus Capecitabine in Metastatic Breast Cancer From a Phase III Clinical Trial
por: Xu, Junnan, et al.
Publicado: (2020)

Case Report: Effective Treatment With Pyrotinib and Capecitabine in a Heavily Pretreated Locally Advanced Breast Cancer Harboring Both HER2 Overexpression and Mutant
por: Gao, Zhichao, et al.
Publicado: (2021)

Effectiveness of Trastuzumab Combined With Capecitabine Treatment in a Patient With Hilar Cholangiocarcinoma Complicated by Liver Metastases With an ERBB2-Activating Mutation: A Case Report
por: Zeng, Daobing, et al.
Publicado: (2022)

Oncological Outcomes After Hippocampus-Sparing Whole-Brain Radiotherapy in Cancer Patients With Newly Diagnosed Brain Oligometastases: A Single-Arm Prospective Observational Cohort Study in Taiwan
por: Lin, Shinn-Yn, et al.
Publicado: (2022)

TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial
por: Wan, Juefeng, et al.
Publicado: (2023)

Haploidentical Stem Cell Transplantation With a Novel Conditioning Regimen in Older Patients: A Prospective Single-Arm Phase 2 Study
por: Sun, Yu-Qian, et al.
Publicado: (2021)

Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study
por: Li, Ning, et al.
Publicado: (2021)

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study
por: Ma, Jingjing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gb1qqha8m5fmlijbe82snr45fv